中文别名 |
(1S,2R)-(-)-1-氨基-2-茚醇;(1S,2R)-顺-(-)-1-氨基-2-茚醇;(1S,2R)-(-)-氨基茚醇;2-氨基-1-茚醇;1-氨基-2-吲哚醇;(1S,2R)-(-)-1-Amino-2-indanol (1S,2R)-(-)-1-氨基-2-茚醇;(1S,2R)-(-)-1-氨基-2-茚醇,(1S,2R)-(-)-cis-1-Amino-2-indanol;(1S,2R)-(-)-1-氨基-2-茚满醇;(1S,2R)-(-)-顺式-1-氨基-2-茚醇;(1S,2R)-1-氨基-2-茚醇;(S)-3-(羟甲基)吡咯烷;N-Boc-顺式-4-羟基-L-脯氨酸甲酯;分散红-1甲苯磺酸盐;顺(-)-1-氨基-2-茚醇;(1S,2R)-(-)-1-氨基-2-羟基茚满;(1S,2R)-(-)-CIS-1-氨-2茚醇;(1S,2R)-(-)-CIS-2-氨基-1-茚醇;(1S,2R)-(-)-顺式-1-氨基-2-茚满醇;顺式(1S,2R)-1-氨基-2-茚醇;2R)-(-)-氨基茚醇;CIS-1-氨基-2-茚醇;(1S,2R)-(-)-顺-1-氨基-2-茚醇 |
英文别名 |
(1S,2R)-1-Amino-2,3-dihydro-1H-inden-2-ol;(1S,2R)-(-)-1-Amino-2-indanol;(1S,2R)-(-)-CIS-1-AMINO-2-HYDROXYINDANE;(1S,2R)-CIS-1-AMINO-2-INDANOL;(1S,2R)-(-)-CIS-1-AMINOINDAN-2-OL;(1S,2R)-(+)-CIS-1-AMINOINDAN-2-OL;(1S,2R)-(-)-1-AMINO-2-HYDROXYINDAN;(1S,2R)-1-AMINO-2-HYDROXYINDANE;(1S,2R)-Trans-1-Amino-2-indanol;(1S,2R)-(-)-(cis)-1-Amino-2-indanol;(1S,2R)-(-)-cis-1-Amino-2-indanol;CIS-1-AMINO-2-INDANOL;(1S,2R)-(-)-1-A;(1S,2R)-(-)-cis-1-Amino-2,3-dihydro-1H-inden-2-ol;(1S,2R)-(−)-cis-1-AMino-2-indanol;(1S,2R)-(?)-cis-1-Amino-2-hydroxyindane;(1S,2R)-(?)-cis-1-Amino-2-indanol;3aR;cis-aminoindanol;(1S,2R)-(−(1S,2R)-1-AMINO-2-INDANOL;KT-1-Amino-2-indanol-0001;(1S,2R)-1-AMINO-INDAN-2-OL;cis-(1S)-Amino-(2R)-indanol;CIS-(1S,2R)-1-AMINO-2-INDANOL;(1S;(1S,2R)-1-Amino-2-indanol;(1s, 2r)-cis-1-amino-2-indanol;1-Amino-2-indanol, cis-(-)-;(1s,2r)-(-)-1amino-2-indanol;2(R)-hydroxy-1(S)-aminoindane;1H-Inden-2-ol, 1-amino-2,3-dihyd;Indinavir sulfate specified impurity A [EP];NS00123249;DTXSID601335000;Indinavir sulfate impurity, cis-aminoindanol- [USP];1-(S)-amino-2-(R)-indanol;BP-12265;cis-(1S, 2R)-1-amino-2-indanol;cis-1-aminoindan-2-ol;UNII-LU3GK925A8;((1S,2R)-2-Hydroxy-2,3-dihydro-1H-inden-1-yl)amine;AKOS005259458;HY-W002530;cis-(-)-1-amino-2-indanol;AKOS004909503;EN300-53940;A15182;INDINAVIR SULFATE IMPURITY, CIS-AMINOINDANOL- [USP IMPURITY];(1s, 2r)-(-)-cis-1-amino-2-indanol;LOPKSXMQWBYUOI-BDAKNGLRSA-N;(1S,2R)-(-)-cis-1-Amino-2-indanol, 99%;1H-Inden-2-ol, 1-amino-2,3-dihydro-, (1S,2R)-;(1S,2R)-1-aminoindan-2-ol;(1S, 2R)-(-)-1-amino-2-indanol;AM20060499;(1S-Cis)-1-amino-2-indanol;MFCD00216655;(2R-Cis)-1-amino-2,3-dihydro-1H-inden-2-ol;CIS-(1S,2R)-AMINOINDAN-2-OL;LU3GK925A8;SCHEMBL83474;(1S, 2R)-1-amino-2-indanol;CS-W002530;Z803127638;DTXSID10155191;AS-30161;W-205248;Q27283183;(1S,2R)-(-)-1-AMINO-2-HYDROXYINDANE;F1905-7167;AC-3533;AC-16728;126456-43-7;(-)-cis-1-aminoindan-2-ol;INDINAVIR SULFATE IMPURITY A [EP IMPURITY];(1S,2R)-1-Amino-2,3-dihydro-1-inden-2-ol;(1S,2R)-(−)-Cis-1-Amino-2-Indanol,98%;DB-030992;INDINAVIR SULFATE IMPURITY, CIS-AMINOINDANOL-[USP IMPURITY];Indinavir sulfate impurity, cis-aminoindanol-[USP];INDINAVIR SULFATE IMPURITY, CIS-AMINOINDANOL-(USP IMPURITY);INDINAVIR SULFATE IMPURITY A (EP IMPURITY);Indinavir sulfate specified impurity A;Indinavir sulfate impurity, cis-aminoindanol-(USP);DTXCID1077682 |